TLDR Coinbase forecasts improving liquidity and institutional growth for crypto markets by 2026. The Fed’s rate cuts and Treasury bill purchases signal a positiveTLDR Coinbase forecasts improving liquidity and institutional growth for crypto markets by 2026. The Fed’s rate cuts and Treasury bill purchases signal a positive

Coinbase Predicts 2026 Crypto Recovery with Improving Liquidity and Support

2025/12/14 16:10
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Coinbase forecasts improving liquidity and institutional growth for crypto markets by 2026.
  • The Fed’s rate cuts and Treasury bill purchases signal a positive liquidity environment for 2026.
  • Volatility remains in crypto markets, but Coinbase sees infrastructure improving for stability.
  • Institutional positioning and liquidity support hint at a more favorable crypto cycle in 2026.

Coinbase Institutional recently pointed to 2026 as a significant turning point for the crypto market. The company believes improving liquidity, Federal Reserve rate cuts, and the continued growth of reserves will set the stage for a potential recovery. With these factors in play, institutional investors are beginning to reposition their capital, and there is optimism about the return of more favorable market conditions in the coming years.

Improving Liquidity and Fed Actions

One of the primary factors behind Coinbase’s positive outlook is the improvement in liquidity across international markets. As of now, the Federal Reserve has cut its benchmark interest rate by 25 basis points and is purchasing up to $40 billion in Treasury bills monthly.

These measures are seen as providing liquidity support rather than full quantitative easing. According to Coinbase, these actions are helping to stabilize reserves and offer support for risk assets, including cryptocurrencies.

The reduced rate environment lowers leverage pressures, which, in turn, benefits the crypto market. For institutional investors, these changes are significant. They signal an opportunity to reposition capital slowly, taking a long-term view on crypto market growth. As liquidity expands, it creates more room for stable growth and recovery, rather than the speculation-driven volatility of previous cycles.

Institutional Positioning and Slow Capital Reallocation

The institutional approach to crypto has shifted, with many funds de-risking during 2025. However, Coinbase notes that capital is now being repositioned more cautiously. Investors are taking a wait-and-see approach, focusing on long-term growth opportunities rather than short-term gains. The slow but steady reallocation of capital to crypto markets is seen as a sign of confidence in the asset class.

This cautious yet deliberate positioning is crucial to Coinbase’s view of 2026. As liquidity continues to improve, more institutions are expected to engage in the market, which will likely drive stability over time. While Coinbase acknowledges the volatility that still exists in the market, it emphasizes the importance of maintaining a structured approach as institutional interest grows.

Volatility and the Need for Enhanced Risk Management

Despite the optimistic outlook, Coinbase also recognizes the ongoing volatility in the market. A notable example of this occurred in October 2025 when a significant liquidation event saw $19 billion in crypto assets sold off, following a sharp drop in Bitcoin’s price. This episode highlights the fragility and liquidity sensitivity of crypto markets, especially when leverage is involved.

However, Coinbase points to improvements in risk management and market infrastructure that may help mitigate such extreme volatility in the future. The company believes that with better infrastructure in place and a more cautious institutional approach, the crypto market will be better equipped to handle these challenges moving forward. Although volatility will persist, the company is optimistic that the market will be better positioned to absorb shocks by 2026.

A Structured Path to Recovery

Coinbase is betting on a gradual recovery in 2026, driven by a combination of liquidity expansion, institutional participation, and the stabilization of financing markets through the Fed’s Treasury bill purchases. The company believes that a steady recovery, rather than a sudden market explosion, will set the stage for long-term growth.

While Coinbase does not predict rapid price increases, it anticipates that crypto will become an increasingly attractive asset for capital as liquidity improves and risks are better managed. The company encourages patience, advising investors to focus on preparation for the next cycle rather than trying to predict its exact timing or intensity.

As 2026 approaches, Coinbase remains confident that the groundwork laid over the past years will help create a more stable and sustainable environment for crypto markets. By focusing on structural growth and liquidity, Coinbase views the coming years as pivotal for the crypto industry’s long-term success.

The post Coinbase Predicts 2026 Crypto Recovery with Improving Liquidity and Support appeared first on CoinCentral.

Market Opportunity
Hive Intelligence Logo
Hive Intelligence Price(HINT)
$0.000922
$0.000922$0.000922
-1.07%
USD
Hive Intelligence (HINT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09